We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
Inspirational women from across the country were invited to Downing Street last week to celebrate International Women’s Day 2024.
There are changes to the legislation of Reference Medicinal Products (RMPs) used to support abridged marketing authorisation applications
A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices.
This guidance covers ‘grandfathering’ and managing the lifecycle changes of medicinal products.
Guidance for industry and organisations to follow from 1 January 2021.
Information on carrying medicine containing controlled drugs for individual travellers entering or leaving the UK.
MHRA statement in response to the study in The Lancet on the use of HRT.
Head of the HRT Taskforce Madelaine McTernan presents key recommendations for future management of hormone replacement therapy (HRT) supply.
Topical steroid products are safe and highly effective treatments for the management of a wide range of inflammatory skin diseases but have important risks, especially with prolonged use at high potency. In the coming months, as a result of regulatory...
We are asking the public for evidence about the use of hormonal pregnancy tests and possible adverse effects in pregnancy including birth defects.
Government action to cut the cost of repeatable HRT prescriptions and a new Menopause Taskforce means women experiencing the menopause will be better supported.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).